Skip to content

GORE TAG Conformable Thoracic Stent Graft TGMR373115Recalls & reported problems

W. L. Gore & Associates, Inc. · CTAG CMDS 37MMX31MMX15CM 22Fr · Class 3 · Implant

All models of GORE TAG Conformable Thoracic Stent Graft (25)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132661688), received between Feb 6, 2026 and Feb 9, 2026 — classified as 2 injuries.

6 other recalls cover devices cleared under the same FDA submission (P040043); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 2 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Paralysis1
  • Post Operative Wound Infection1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 9, 2026Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2026, THE PATIENT UNDERWENT AN ENDOVASCULAR PROCEDURE TO TREAT AN ANEURYSM UTILIZING GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS. THE PATIENT TOLERATED THE PROCEDURE. IT WAS REPORTED ON THE NEXT DAY, THE PATIENT LOST BILATERAL LOWER EXTREMITY MOTOR FUNCTION. A SPINAL DRAIN WAS PLACED PRE-OPERATIVELY AS A PRECAUTION, AND WAS FUNCTIONING CORRECTLY. IT WAS ALSO REPORTED THERE WERE NO ISSUES OBSERVED DURING THE PROCEDURE WITH ANY OF THE GORE DEVICES. THE PHYSICIAN ATTRIBUTES THIS PARALYSIS DUE TO TOTAL COVERAGE OF THE THORACIC AND ABDOMINAL AORTA AT SAME STAGE, AND DOES NOT BELIEVE THE GORE DEVICES CAUSED THE PARALYSIS. NO FURTHER PATIENT INFORMATION IS AVAILABLE.

    Patient problems: Paralysis

    MAUDE report 24293506 ↗
  • InjuryFeb 6, 2026Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2025, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A ZONE 0 (ASCENDING AORTA) WITH BCA (BRACHIOCEPHALIC ARTERY) TEVAR TREATMENT FOR ANEURYSM FROM A DISSECTION. THE PATIENT WAS IMPLANTED WITH GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS DEVICE AND GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM (TSB121706A, TGMR373115, TSB121706A, TAC124515A, TE4546A). THE PATIENT TOLERATED THE PROCEDURE WITH GOOD RESULTS. ON (B)(6) 2026, THE PATIENT UNDERWENT REINTERVENTION TO TREAT CONTINUED ANEURYSMAL DEGENERATION OF THE ANEURYSM DUE TO INFECTION OF THE PATIENT¿S AORTA AND OF THE ANEURYSM. THE SIDE BRANCH DEVICE WAS EXTENDED PROXIMALLY AND THE TBE AORTIC COMPONENT WAS EXTENDED WITH A CTAG. THE PATIENT TOLERATED THE PROCEDURE. THE CAUSE OF THE INFECTION IS NOT KNOWN. THE PHYSICIAN REPORTS THAT AT THE PATIENT¿S 30-DAY FOLLOW-UP COMPUTED TOMOGRAPHY (CT) ALL LOOKED GOOD HEALTHY AND NO DEVICE ISSUES OR CONCERNS NOTED. THE PATIENT HAD OBSERVED DEVICE ISSUES. THE PATIENT THEN STATED THEY HAD A FOLLOW-UP CT AT ANOTHER HOSPITAL IN (B)(6) AND THE AORTA HAD GOTTEN PROGRESSIVELY WORSE. THE PHYSICIAN DOES NOT KNOW IF THERE WAS UNDETECTED INFECTION AT THE TIME OF THE INDEX PRO

    Patient problems: Post Operative Wound Infection

    MAUDE report 24283600 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P040043. One submission often covers many models, so check the product and lot details in each record.

  • Z-0290-2021 · Sep 9, 2020 · Open, Classified
    GORE TAG CONFORMABLE Thoracic Stent Graft with ACTIVE CONTROL System
  • Z-0291-2021 · Sep 9, 2020 · Open, Classified
    GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
  • Z-2052-2020 · Dec 17, 2019 · Terminated
    Conformable Thoracic Stent Graft, Rx only, Sterile EO - Product Usage: This device is intended for endovascular repair of lesions of the descending thoracic aorta.
  • Z-0048-2018 · Sep 25, 2017 · Terminated
    GORE TAG, THORACIC ENDOPROSTHESIS, CONFORMABLE. The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta.
  • Z-1236-06 · Apr 28, 2006 · Terminated
    GORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3410, 34mm x 10cm
  • Z-1237-06 · Apr 28, 2006 · Terminated
    GORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3415, 34mm x 15cm

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page